Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular: A report from the Children's Cancer Group

Cancer

Volumn 89, Issue 5, 2000, Pages 1150-1161

  Umehara, Shunsuke ^a   Nakagawa, Atsuko ^a   Matthay, Katherine K ^b   Lukens, John N ^c   Seeger, Robert C ^a   Stram, Daniel O ^d   Gerbing, Robert B ^d   Shimada, Hiroyuki ^a,d  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Composite; Favorable subset; Ganglioneuroblastoma; Histopathology; Inte rnational Classification; Neuroblastic tumors; Nodular; Prognosis; Shimada system; Unfavorable subset

Indexed keywords

AGE; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL STRUCTURE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR CLASSIFICATION;

AGE FACTORS; CHILD, PRESCHOOL; GANGLIONEUROBLASTOMA; HUMANS; INFANT; NEOPLASM STAGING; PROGNOSIS;

EID: 0034284074     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000901)89:5<1150::AID-CNCR25>3.0.CO;2-7     Document Type: Article

References (13)

1. Histopathologic prognostic factors in neuroblastic tumors; definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas
2. Histopathologic features of composite ganglioneuroblastoma: Immunohistochemical distinction of the stromal component is related to prognosis
3. Evidence for molecular heterogeneity in human ganglioneuroblastoma
4. Ganglioneuroma of the sympathetic nervous system
5. Ganglioneuroblastoma Of the posterior mediastinum: A clinicopathologic review of 80 cases
6. Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee
7. The International Neuroblastoma Pathology Classification (Shimada system)
8. Successful treatment for Stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group Study
9. A proposed staging for children with neuroblastoma: Children's Cancer Study Group A
10. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
11. Favorable biology and outcome of Stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study
12. Biologic variables in the outcome of Stages I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study
13. Nonparametric estimation from incomplete Observations